WeightWatchers News

Latest stories

Weight loss drugs reshape industry, Jon Gosselin credits Ozempic for 30-pound weight loss despite side effects and high cost
Authors
34
2 months
Culture
Oprah's 'Shame, Blame, Revolution' Special Explores Weight Loss Drugs Ozempic, Mounjaro
Authors
43
4 months
Crime
Culture
Ozempic Surge Sparks Legal Action, Financial Strains with $20k Cap, and Safety Debates
Authors
15
4 months
Culture
Novo Nordisk, Eli Lilly face challenges amid rising demand for Ozempic and Wegovy
Authors
10
4 months
Economics
Crime
Business
Oprah Exits WeightWatchers Board Since 2015, Amid Ozempic Age Challenges
Authors
15
4 months
Culture
Oprah's Exit from WeightWatchers Board Causes Stock Price Plunge
Authors
5
4 months
Economics
Business
Oprah Exits WeightWatchers Board, Donates 10% Stake as Shares Fall 23.5%
Authors
59
4 months
Culture
Weight loss drug use surges in US, impacting WeightWatchers amid Ozempic, Wegovy, GLP-1 competition
Authors
6
4 months
Chicago
Politics
WeightWatchers Sponsors Ozempic Hype House, Focuses on GLP-1 Medication
Authors
5
4 months
Culture
Ozempic Weight Loss Drug Gains Attention with 'Hype House' Sponsored by WeightWatchers, Experts Warn of Potential Side Effects and Long-Term Health Impacts
Authors
11
4 months
Culture
Eli Lilly's 2024 Direct-to-Consumer Telehealth and Home Delivery of Weight Loss Drugs
Authors
14
6 months
Economics
Business
Eli Lilly Launches LillyDirect for Zepbound Telehealth Prescriptions
Authors
18
6 months
Economics
Business
Oprah Winfrey Admits to Using Ozempic, Wegovy; WeightWatchers Launches Program for Weight-Loss Drug Users
Authors
12
7 months
Culture
Pfizer Stock Plummets as WeightWatchers Prescribes Weight Loss Drugs Amid Covid Booster Decline and Serious Side Effects
Authors
5
7 months
Politics
Oprah Winfrey Confirms Use of Eli Lilly's Zepbound for 40-Pound Weight Loss Transformation
Authors
28
7 months
Culture
Obesity Drug Market to Reach $80 Billion, Employers Turn to Teladoc for Weight-Loss Programs, Medifast and WeightWatchers Enter Market for GLP-1 Medications
Authors
12
7 months
Economics
Business
M&A Activity Surges in Obesity Drug Space as Medifast Partners with LifeMD, Novo Nordisk's Wegovy, and WeightWatchers Launches New Program
Authors
4
7 months
Economics
Business
Novo Nordisk's Weight Loss Drugs Gain Attention, Altimmune Surges 66%, WeightWatchers to Offer Ozempic; Lawsuit Over Impure Wegovy; Doctors Received Payments from Novo Nordisk
Authors
12
7 months
Economics
Business
Semaglutide Reduces Cardiovascular Risk in Obesity; Ozempic, Mounjaro Popularity Raises Access Questions
Authors
14
8 months
Economics
Business